| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ernexa Therapeutics Inc. (ERNA) has 0 insiders with recent SEC Form 4 filings, including 5 buys and 11 sells. ERNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2020 | Ellin Robert S63 | 10% Owner | Sell | 12,500 | $5.99 | $74,910.00 | -3.1% | |
| Jun 3, 2020 | Berg Jeffrey Alan | 10% Owner | Sell | 21,932 | $1.10 | $24,059.40 | -7.4% | |
| Jun 2, 2020 | Berg Jeffrey Alan | 10% Owner | Sell | 60,730 | $1.02 | $62,192.70 | -8.8% | |
| May 29, 2020 | Berg Jeffrey Alan | 10% Owner | Sell | 37,338 | $1.07 | $39,799.72 | -4.8% | |
| May 27, 2020 | Berg Jeffrey Alan | 10% Owner | Sell | 25,000 | $1.09 | $27,320.00 | -3.0% | |
| Dec 23, 2019 | Berg Jeffrey Alan | 10% Owner | Sell | 1,900 | $2.69 | $5,114.00 | -0.2% | |
| Dec 20, 2019 | Ellin Robert S63 | 10% Owner | Buy | 400 | $2.82 | $1,126.99 | +0.1% | |
| Dec 19, 2019 | Ellin Robert S63 | 10% Owner | Buy | 299 | $2.72 | $814.30 | +0.2% | |
| Dec 5, 2019 | Ellin Robert S63 | 10% Owner | Buy | 100 | $2.90 | $290.00 | - | |
| Oct 29, 2019 | Ellin Robert S63 | 10% Owner | Buy | 881 | $3.15 | $2,776.12 | +0.4% |